Aldeyra Therapeutics, Inc. ALDX
- reproxalap — Dry Eye Disease NDA Submitted
- reproxalap — Allergic Conjunctivitis Phase 3
- ADX-248 — Atopic Dermatitis Phase 1
- ADX-246 — Age-Related Macular Degeneration Preclinical
- ADX-248 Preclinical
- ADX-246 Preclinical